IL5 and chronic rhinosinusitis with nasal polyps: Gevaert’s study on CRSwNP patients, in which a single intravenous infusion of reslizumab was administered confirmed that NP scores improved only in half of the patients and increased nasal IL-5 levels predicted the response to anti-IL-5 treatment [134].